Delivery Order SPE2DU25D9815-SPE2DU25F0E85
- Not listed
- The Defense Logistics Agency issued a delivery order valued at $5,170.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, awarded on August 15, 2025, with an ultimate completion date of September 8, 2025, is issued under the company's larger Indefinite Delivery Contract with DLA valued at $499.99 million and valid through November 2026. The delivery order employs firm fixed-price pricing and carries no...
- The Defense Logistics Agency awarded a $97,499.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, with an ultimate completion date of August 5, 2025. This delivery order, issued under the SPE2DB Indefinite Delivery Contract valued at $500 million through November 2026, represents a continuation of the agency's pharmaceutical supply relationship with the vendor. The award carries no set-aside...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $16,632.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on July 23, 2025, represents one of numerous task orders issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $500 million through November 2026....
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a firm fixed-price delivery order valued at $46,257.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing $500 million Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain issued a firm fixed-price delivery order valued at $219,454.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, which was awarded on August 12, 2025, with an ultimate completion date of August 19, 2025, represents a component of DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $37,053.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has an ultimate completion date of August 29, 2024, is for the delivery of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,785.80 by the Defense Logistics Agency's Medical Supply Chain division on August 15, 2025. This delivery order, issued without a set-aside designation, represents a single task order under the company's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency valued at $499,999,999 through November 2026....
- This delivery order, valued at $12,115.65, was awarded on August 11, 2025, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award represents a firm fixed-price delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, a $500 million contract vehicle valid through November 2026. The delivery order will be performed in Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $38k firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on August 11, 2025. This delivery order, with an ultimate completion date of August 19, 2025, represents a task order issued under the company's larger Indefinite Delivery Contract with the DLA valued at $500 million and extending through November 2026. The award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 on August 12, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which is scheduled for completion by August 13, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499.999 billion through November...
- SPE2DU25D9815Indefinite Delivery Contract
- SPE2DU25D9815-SPE2DU25F0E85Delivery Order
The Defense Logistics Agency issued a delivery order valued at $1,526.37 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order falls under the SPE2DB Indefinite Delivery Contract (IDC), a $500 million single-award vehicle through which DLA procures pharmaceutical products and medical supplies for Department of Defense healthcare facilities. No set-aside designation was applied to this award, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its small business status. DMS Pharmaceutical Group leverages its position as a critical supplier within the federal pharmaceutical supply chain to deliver a comprehensive range of products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to military health facilities nationwide. The company has maintained consistent contract performance under the SPE2DB program, which enables DLA to issue delivery orders for specific pharmaceutical items as needed to support the medical supply requirements of Department of Defense installations worldwide. This delivery order represents a routine procurement action within the company's established relationship with DLA for pharmaceutical distribution services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/14/25 |